Oxford, United Kingdom
HydRegen, founded in 2020 and headquartered in the United Kingdom, is revolutionizing the chemical production industry with its innovative biotechnology platforms. The company's core mission, as captured in its slogan, is to "transform chemical production economics, sustainability and safety with novel biocatalyst platforms."
HydRegen specializes in developing sustainable and cost-efficient chemical processes that serve as 'slot in' replacements for traditional precious metal catalysts, thus facilitating the transition towards more sustainable manufacturing methods across various chemical sectors. The company's partnerships with major chemicals firms underscore the verified applicability and scalability of these technologies.
Currently, HydRegen is seeking an investment between £5-8 million to commercialize its first product, Bio2Amine, aiming at an £80 billion market with a projected £105 million in recurring revenue. The company has previously secured a £2.60 million seed investment from Clean Growth Fund.
